Ginkgo Bioworks shares surge 12.78% intraday following partnerships with Carnegie Mellon and Agricen.

Ginkgo Bioworks (DNA) surged 12.78% intraday following announcements of strategic partnerships and research collaborations. The company revealed a collaboration with Carnegie-Mellon University to develop a cancer screening approach and a partnership with Agricen to optimize agricultural soil amendment manufacturing. Additionally, Ginkgo Bioworks announced participation in the 44th Annual J.P. Morgan Healthcare Conference, a high-profile event likely boosting investor visibility. These developments signaled expanded market opportunities and technological advancements, outweighing recent quarterly losses and negative earnings, and driving immediate bullish sentiment.